Literature DB >> 9598986

Reconstituted adenine nucleotide translocase forms a channel for small molecules comparable to the mitochondrial permeability transition pore.

A Rück1, M Dolder, T Wallimann, D Brdiczka.   

Abstract

Highly purified adenylate translocase (ANT) from rat heart mitochondria was functionally reconstituted as ATP/ADP exchange carrier in asolectin/cardiolipin vesicles. The ANT preparations used were free of porin, cyclophilin D, and Bax as analysed immunologically and by activity measurements. After pre-loading the ANT-containing proteoliposomes with ATP, malate or AMP, a gradual release of the trapped compounds by increasing the external Ca2+ concentrations could be demonstrated. N-Methyl-Val-4-cyclosporin did not inhibit the Ca2+ dependent release of internal substances from ANT liposomes. This inhibitor was found to be specific for the mitochondrial permeability transition pore (MTP) in intact mitochondria or reconstituted MTP-like protein complexes (e.g. hexokinase, porin, ANT complex). However, ADP in concentrations > 20 microM inhibited the liberation of internal compounds, while in contrast, atractyloside (30 microM) and HgCl2 (5 microM) both induced permeability of the ANT-containing liposomes resulting in a release of trapped substances. These results strongly suggest that ANT itself is capable to adopt a pore-like structure under conditions known to induce the permeability transition in mitochondria.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9598986     DOI: 10.1016/s0014-5793(98)00317-2

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  36 in total

1.  Dual responses of CNS mitochondria to elevated calcium.

Authors:  N Brustovetsky; J M Dubinsky
Journal:  J Neurosci       Date:  2000-01-01       Impact factor: 6.167

2.  Control of the mitochondrial permeability transition pore by high-affinity ADP binding at the ADP/ATP translocase in permeabilized mitochondria.

Authors:  R A Haworth; D R Hunter
Journal:  J Bioenerg Biomembr       Date:  2000-02       Impact factor: 2.945

Review 3.  Mitofusins and the mitochondrial permeability transition: the potential downside of mitochondrial fusion.

Authors:  Kyriakos N Papanicolaou; Matthew M Phillippo; Kenneth Walsh
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-05-25       Impact factor: 4.733

4.  Cardiolipin Interactions with Proteins.

Authors:  Joan Planas-Iglesias; Himal Dwarakanath; Dariush Mohammadyani; Naveena Yanamala; Valerian E Kagan; Judith Klein-Seetharaman
Journal:  Biophys J       Date:  2015-08-20       Impact factor: 4.033

Review 5.  The mitochondrial permeability transition in neurologic disease.

Authors:  M D Norenberg; K V Rama Rao
Journal:  Neurochem Int       Date:  2007-03-04       Impact factor: 3.921

Review 6.  Fundamental Mechanisms of Regulated Cell Death and Implications for Heart Disease.

Authors:  Dominic P Del Re; Dulguun Amgalan; Andreas Linkermann; Qinghang Liu; Richard N Kitsis
Journal:  Physiol Rev       Date:  2019-10-01       Impact factor: 37.312

Review 7.  The still uncertain identity of the channel-forming unit(s) of the mitochondrial permeability transition pore.

Authors:  Christopher P Baines; Manuel Gutiérrez-Aguilar
Journal:  Cell Calcium       Date:  2018-05-16       Impact factor: 6.817

Review 8.  The molecular composition of the mitochondrial permeability transition pore.

Authors:  Christopher P Baines
Journal:  J Mol Cell Cardiol       Date:  2009-02-20       Impact factor: 5.000

9.  Direct demonstration of a specific interaction between cyclophilin-D and the adenine nucleotide translocase confirms their role in the mitochondrial permeability transition.

Authors:  K Woodfield; A Rück; D Brdiczka; A P Halestrap
Journal:  Biochem J       Date:  1998-12-01       Impact factor: 3.857

10.  VDAC and peripheral channelling complexes in health and disease.

Authors:  Mikhail Vyssokikh; Dieter Brdiczka
Journal:  Mol Cell Biochem       Date:  2004 Jan-Feb       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.